Page last updated: 2024-08-18

isomethyleugenol and Hamartoma Syndrome, Multiple

isomethyleugenol has been researched along with Hamartoma Syndrome, Multiple in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Al-Sohaily, S; Biankin, A; Kohonen-Corish, M; Leong, R; Warusavitarne, J1
Chang, R; Chang, YW; Chi, SG; Dong, SH; Kim, BH; Kim, HJ; Kim, WK; Kim, YW; Lee, JI; Min, HJ; Park, BJ; Park, JH; Yang, MH1

Reviews

1 review(s) available for isomethyleugenol and Hamartoma Syndrome, Multiple

ArticleYear
Molecular pathways in colorectal cancer.
    Journal of gastroenterology and hepatology, 2012, Volume: 27, Issue:9

    Topics: Adenomatous Polyposis Coli; Cell Transformation, Neoplastic; Chromosomal Instability; Colorectal Neoplasms; Colorectal Neoplasms, Hereditary Nonpolyposis; CpG Islands; Hamartoma Syndrome, Multiple; Humans; Methylation; Microsatellite Instability; Peutz-Jeghers Syndrome

2012

Other Studies

1 other study(ies) available for isomethyleugenol and Hamartoma Syndrome, Multiple

ArticleYear
Mutational abrogation of the PTEN/MMAC1 gene in gastrointestinal polyps in patients with Cowden disease.
    Gastroenterology, 1998, Volume: 115, Issue:5

    Topics: Adolescent; Adult; Alleles; Female; Gastrointestinal Diseases; Gene Deletion; Gene Expression Regulation; Germ-Line Mutation; Hamartoma Syndrome, Multiple; Humans; Methylation; Mutation; Mutation, Missense; Phosphoric Monoester Hydrolases; Polyps; PTEN Phosphohydrolase; RNA, Messenger; Transcription, Genetic; Tumor Suppressor Proteins

1998